Basel, Switzerland

John Darbyshire

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Gmbh & Co Kg. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Darbyshire. Retrieved from https://idiyas.com/inventor/john-darbyshire-mb1q6dsf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Darbyshire: Innovator in Pharmaceutical Chemistry

Introduction

John Darbyshire is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target dopamine receptors. His work has implications for treating various disorders that respond to dopamine antagonists or agonists.

Latest Patents

John Darbyshire holds 1 patent related to his innovative work. The patent involves compounds of a specific formula that are used in pharmaceutical compositions. These compositions include at least one triazole compound and are designed to treat disorders that can benefit from dopamine receptor modulation.

Career Highlights

Darbyshire is currently associated with Abbott GmbH & Co. KG, a leading company in the pharmaceutical industry. His role at Abbott allows him to leverage his expertise in drug development and contribute to advancements in medical treatments.

Collaborations

Throughout his career, John has collaborated with talented professionals such as Liliane Unger and Andreas Haupt. These collaborations have fostered a productive environment for innovation and research.

Conclusion

John Darbyshire's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective treatments for various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…